DSM appoints new Executive Vice President Corporate Strategy & Acquisitions

25-Aug-2011 - Netherlands

Single crystal diffractometer - XRD Line of Instruments for Small Molecule and Protein Crystallography

$Single crystal diffractometer - XRD Line of Instruments for Small Molecule and Protein Crystallography$

Next Generation DLS Instrument with the Novel Polarisation-separated Backscatter PCCS | NANOPHOX CS

Fast and effective neutralisation of acid fumes

Royal DSM announces the following:

Philip Eykerman, (1968), currently Partner at McKinsey & Company, Brussels office, will join DSM as Executive Vice President Corporate Strategy & Acquisitions, reporting to Feike Sijbesma, CEO and Chairman of the Managing Board of DSM.

Philip will succeed Hein Schreuder, currently EVP Corporate Strategy & Acquisitions, who after a very successful career of 20 years at DSM, will retire from the company on December 31, 2011. Hein has played a key role in the transformation of DSM as well as in the acquisitions and divestments of the company during the last 15 years.

Philip, a Belgian national, joined McKinsey & Company in 1997 and is the leader of McKinsey's Chemicals Practice in the Benelux and France. He has been heavily involved in a number of significant strategy development, transformation and M & A projects in the broader chemicals industry.

With his track record of strategy development and M & A strategy and integration, Philip is well positioned to lead DSM's corporate strategy and acquisition department and drive the development of DSM's strategic growth agenda.

https://www.chemeurope.com/en/news/134067/dsm-appoints-new-executive-vice-president-corporate-strategy-acquisitions.html